Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$507K Sell
7,174
-676
-9% -$51.4K ﹤0.01% 1961
2020
Q3
$620K Sell
7,850
-73
-0.9% -$5.92K ﹤0.01% 1697
2020
Q2
$778K Buy
7,923
+725
+10% +$84.3K ﹤0.01% 1539
2020
Q1
$1.01M Buy
7,198
+2,846
+65% +$326K ﹤0.01% 1300
2019
Q4
$418K Sell
4,352
-111
-2% -$8.62K ﹤0.01% 1902
2019
Q3
$298K Buy
4,463
+298
+7% +$26.9K ﹤0.01% 2021
2019
Q2
$359K Buy
4,165
+686
+20% +$46.2K ﹤0.01% 1945
2019
Q1
$217K Buy
+3,479
New +$192K ﹤0.01% 2132

Other funds holding EHTH

Aperio Group's EHTH Position: Q4 2020 in Review

Aperio Group reduced its eHealth (EHTH) stake by 8.6% in Q4 2020, selling an estimated $51.4K and leaving 7,174 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #1961.

Aperio Group first reported a position in EHTH in Q1 2019 and has held it in 8 quarters since. The position peaked at $1.01M in Q1 2020. 240 funds tracked by Wall St. Rank hold EHTH as of Q4 2020.

  • Aperio Group held 7,174 shares of eHealth worth $507K as of Q4 2020.
  • Aperio Group sold 676 eHealth shares in Q4 2020, an estimated $51.4K.
  • eHealth made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1961 holding.
  • Aperio Group first reported a position in eHealth in Q1 2019 and has held it in 8 quarters since.
  • Aperio Group's eHealth position peaked at $1.01M in Q1 2020.
  • 240 funds tracked by Wall St. Rank held eHealth as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.